Smooth Muscle Insulin Receptor Deletion Causes Voiding Dysfunction : A Mechanism for Diabetic Bladder Dysfunction
© 2022 by the American Diabetes Association..
Diabetic bladder dysfunction (DBD) is the most common complication in diabetes. Myogenic abnormalities are common in DBD; however, the underlying mechanisms leading to these remain unclear. To understand the importance of smooth muscle insulin receptor (IR)-mediated signaling in the pathogenesis of DBD, we conditionally deleted it to achieve either heterozygous (SMIR+/-) or homozygous (SMIR-/-) deletion in smooth muscle cells. Despite impaired glucose and insulin tolerance seen with SMIR-/- mice, both SMIR+/- and SMIR-/- mice exhibited normal blood glucose and plasma insulin levels. Interestingly, these mice had abnormal voiding phenotypes, that included urinary frequency and small voids, and bladder smooth muscle (BSM) had significantly diminished contraction force. Morphology revealed a dilated bladder with thinner BSM layer, and BSM bundles were disorganized with penetrating interstitial tissue. Deletion of IR elevated FoxO and decreased mTOR protein expression, which further decreased the expression of Chrm3, P2x1, Sm22, and Cav1.2, crucial functional proteins for BSM contraction. Furthermore, we determined the expression of adiponectin in BSM, and deletion of IR in BSM inhibited adiponectin-mediated signaling. In summary, disruption of IR-mediated signaling in BSM caused abnormalities in proliferation and differentiation, leading to diminished BSM contractility and a voiding dysfunction phenotype that recapitulates human DBD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Diabetes - 71(2022), 10 vom: 01. Okt., Seite 2197-2208 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Huan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 23.09.2022 Date Revised 02.10.2023 published: Print figshare: 10.2337/figshare.20349528 Citation Status MEDLINE |
---|
doi: |
10.2337/db22-0233 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343965348 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343965348 | ||
003 | DE-627 | ||
005 | 20231226021651.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/db22-0233 |2 doi | |
028 | 5 | 2 | |a pubmed24n1146.xml |
035 | |a (DE-627)NLM343965348 | ||
035 | |a (NLM)35876633 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Huan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Smooth Muscle Insulin Receptor Deletion Causes Voiding Dysfunction |b A Mechanism for Diabetic Bladder Dysfunction |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.09.2022 | ||
500 | |a Date Revised 02.10.2023 | ||
500 | |a published: Print | ||
500 | |a figshare: 10.2337/figshare.20349528 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 by the American Diabetes Association. | ||
520 | |a Diabetic bladder dysfunction (DBD) is the most common complication in diabetes. Myogenic abnormalities are common in DBD; however, the underlying mechanisms leading to these remain unclear. To understand the importance of smooth muscle insulin receptor (IR)-mediated signaling in the pathogenesis of DBD, we conditionally deleted it to achieve either heterozygous (SMIR+/-) or homozygous (SMIR-/-) deletion in smooth muscle cells. Despite impaired glucose and insulin tolerance seen with SMIR-/- mice, both SMIR+/- and SMIR-/- mice exhibited normal blood glucose and plasma insulin levels. Interestingly, these mice had abnormal voiding phenotypes, that included urinary frequency and small voids, and bladder smooth muscle (BSM) had significantly diminished contraction force. Morphology revealed a dilated bladder with thinner BSM layer, and BSM bundles were disorganized with penetrating interstitial tissue. Deletion of IR elevated FoxO and decreased mTOR protein expression, which further decreased the expression of Chrm3, P2x1, Sm22, and Cav1.2, crucial functional proteins for BSM contraction. Furthermore, we determined the expression of adiponectin in BSM, and deletion of IR in BSM inhibited adiponectin-mediated signaling. In summary, disruption of IR-mediated signaling in BSM caused abnormalities in proliferation and differentiation, leading to diminished BSM contractility and a voiding dysfunction phenotype that recapitulates human DBD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 7 | |a Adiponectin |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a CHRM3 protein, human |2 NLM | |
650 | 7 | |a Insulins |2 NLM | |
650 | 7 | |a Receptor, Muscarinic M3 |2 NLM | |
650 | 7 | |a Receptor, Insulin |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a TOR Serine-Threonine Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
700 | 1 | |a Wu, Ali |e verfasserin |4 aut | |
700 | 1 | |a Zeidel, Mark L |e verfasserin |4 aut | |
700 | 1 | |a Yu, Weiqun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes |d 1952 |g 71(2022), 10 vom: 01. Okt., Seite 2197-2208 |w (DE-627)NLM000060011 |x 1939-327X |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2022 |g number:10 |g day:01 |g month:10 |g pages:2197-2208 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/db22-0233 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2022 |e 10 |b 01 |c 10 |h 2197-2208 |